Baricitinib Misses Key Safety Benchmark in High-Risk RA

Published Date: 08 Jun 2026

Patients with RA have a higher risk of blood clots and serious infections with baricitinib vs older biologics, but not heart disease or cancer, according to two safety trials.

Read Full News

Latest News


News All Time

HTTP error: 503HTTP error: 503 HTTP error: 503
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Alternative breast imaging techniques beyond mammography.

2.

Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars

3.

Capivasertib Wins Metastatic Prostate Cancer Approval

4.

Fixed-Duration Combo Shows Promise for Relapsed MCL

5.

Q&A: Breast cancer facts that could save lives


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot